好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Neuronal ??-Synucleinopathy Distribution Within the Hippocampal Circuit Correlates with Microglial Activity in the CA2 Hippocampal Subfield of Lewy Body Dementia Patients
Aging, Dementia, and Behavioral Neurology
P11 - Poster Session 11 (11:45 AM-12:45 PM)
13-004

Lewy body diseases (LBDs) evolve by spreading of intraneuronal protein aggregates comprised of α-synuclein, termed neuronal α-synucleinopathy (NAS). In the absence of reliable in vivo imaging to detect NAS, histopathological staging is critical to understand LBD pathogenesis but seldom accounts for microglial activity within well-established circuits. Here, we address this key knowledge gap by testing the hypothesis that microglial activity mirrors NAS accumulation within the well-defined hippocampal circuit.

NAS is associated with increased microglial activity but there is conflicting evidence to the role of microglia in LBDs. NAS in the hippocampus develops preferentially in certain subfields, and here, we used a focused digital histopathologic study to evaluate the association of microglial activity with NAS distribution using NAS positivity within the well-studied hippocampal circuit to model transsynaptic NAS spread.

We isolated autopsy-confirmed hippocampal NAS with minimal age-related co-pathologies (n=62). Consecutive hippocampal sections were immunostained for NAS and microglial markers, Iba1, HLA-DR, and CD68. We measured the percent area occupied (%AO) in hippocampal subfields (Subiculum, CA1-4, and Dentate Gyrus). We used linear-mixed effects models with subfield as a fixed factor to compare the normalized %AO across subfields while co-varying for demographics and determined the association of microglial activity with NAS within and between subfields using non-parametric correlations.

There was significantly higher NAS and microglial activity in the CA2 compared to most other hippocampal subregions (β=-0.99- -0.18, p<0.05). Interestingly, within-region correlations between NAS and CD68 and HLA-DR were observed only in the CA2 (ρ=0.33-0.26, p<0.05). In contrast, CA2 microglial activity with these markers correlated with NAS in distant subfields (CA4 and Dentate Gyrus) with retrograde connectivity to the CA2 (ρ=0.43-0.36, p<0.01).

Our data suggest that focal microglial activity in the CA2 is associated with NAS development specifically within the CA2 and with retrograde distribution of NAS to distant hippocampal subfields.

Authors/Disclosures
Esteban Luna, MD, PhD (Hospital of the University of Pennsylvania Neurology Department)
PRESENTER
Dr. Luna has nothing to disclose.
Katheryn A. Cousins, PhD The institution of Prof. Cousins has received research support from NIA. The institution of Prof. Cousins has received research support from DoD.
Sheina Emrani, PhD Dr. Emrani has nothing to disclose.
Winifred Trotman Ms. Trotman has nothing to disclose.
Daniel Weintraub Daniel Weintraub has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Clintrex. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scion. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sunovion. Daniel Weintraub has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Modality.ai. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerevel. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CuraSen. Daniel Weintraub has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boehringer Ingelheim. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Daniel Weintraub has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia. Daniel Weintraub has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorder Society. The institution of Daniel Weintraub has received research support from NIH. The institution of Daniel Weintraub has received research support from Fox Foundation. The institution of Daniel Weintraub has received research support from IPMDS. Daniel Weintraub has received intellectual property interests from a discovery or technology relating to health care.
Alice Chen-Plotkin, MD Dr. Chen-Plotkin has received intellectual property interests from a discovery or technology relating to health care.
Edward Lee Edward Lee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Edward Lee has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Rainwater Foundation. Edward Lee has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for South Texas ADRC. Edward Lee has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for 1Florida ADRC. The institution of Edward Lee has received research support from NIH. The institution of Edward Lee has received research support from Delaware Community Foundation. The institution of Edward Lee has received research support from Chan Zuckerberg Institute. Edward Lee has received intellectual property interests from a discovery or technology relating to health care. Edward Lee has received personal compensation in the range of $0-$499 for serving as a Speaker (travel) with Chan Zuckerber Institute. Edward Lee has received personal compensation in the range of $0-$499 for serving as a Speaker (travel) with ALS Network. Edward Lee has received personal compensation in the range of $0-$499 for serving as a Speaker (travel) with Academic Institutions & Universities. Edward Lee has received personal compensation in the range of $0-$499 for serving as a Speaker (travel) with Gordon Research Conferences.
David Irwin, MD (University of Pennsylvania) The institution of Dr. Irwin has received research support from NIH. The institution of Dr. Irwin has received research support from Prevail. The institution of Dr. Irwin has received research support from Passage Bio. The institution of Dr. Irwin has received research support from Alector. The institution of Dr. Irwin has received research support from Transposon. The institution of Dr. Irwin has received research support from Denali. The institution of Dr. Irwin has received research support from Cervo Med.